Therapeutic Advances in Musculoskeletal Disease
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
- PublisherSAGE PUBLICATIONS LTD
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesUSD 2300
- Publication Time18
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2009
- Publisher URL
- Website URL
- Plagiarism
- Publication Time18
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC BY-NC
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 0% |
| 4-6 | 23% |
| 7-9 | 60% |
| >9 | 18% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Therapeutic Advances in Musculoskeletal Disease been publishing? 
The Therapeutic Advances in Musculoskeletal Disease has been publishing since 2009 till date.
How frequently is the Therapeutic Advances in Musculoskeletal Disease published?
Therapeutic Advances in Musculoskeletal Disease is published Continuous publication.
What is the H-index. SNIP score, Citescore and SJR of Therapeutic Advances in Musculoskeletal Disease?
Therapeutic Advances in Musculoskeletal Disease has a H-index score of 44, Citescore of 3.7, SNIP score of 1.17, & SJR of Q1
Who is the publisher of Therapeutic Advances in Musculoskeletal Disease?
The publisher of Therapeutic Advances in Musculoskeletal Disease is SAGE PUBLICATIONS LTD.
How can I view the journal metrics of Therapeutic Advances in Musculoskeletal Disease on editage?
For the Therapeutic Advances in Musculoskeletal Disease metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Therapeutic Advances in Musculoskeletal Disease?
The eISSN number is 1759-7218 and pISSN number is 1759-720X for Therapeutic Advances in Musculoskeletal Disease.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Rheumatoid arthritis, Psoriatic arthritis, Hyaluronic acid, Ankylosing spondylitis, Osteoporosis, Glucosamine, Odds ratio, Diagnostic accuracy, Fibromyalgia, Axial spondyloarthritis, Osteoarthritis, Functional disability, Janus kinase inhibitor, Disease activity, Cancer, Scoring system, Sarcopenia, Systematic review, Rheumatoid factor, Confidence interval.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.